novo nordisk mim8 - Search News

News

Novo Nordisk to sell Wegovy through telehealth firms

Hims & Hers surges on partnership with Novo Nordisk for Wegovy

Hims & Hers Health (HIMS) stock surges following a partnership with Novo Nordisk (NVO) to sell the Danish drugmaker's weight loss drug, Wegovy. Read more here.

The Hill on MSN · 1d

Novo Nordisk partners with Ro, Hims and LifeMD to sell low-cost Wegovy

Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular weight-loss drug Wegovy. The pharmaceutical company announced it would

The Wall Street Journal on MSN · 2d

Hims & Hers to Sell Novo Nordisk’s Wegovy in U.S., Shares Soar

Him & Hers Health and Novo Nordisk are collaborating to offer weight-loss treatment, including access to Wegovy along with other services to treat obesity.

Zacks Investment Research on MSN2d

Novo Nordisk Before Q1 Earnings: How Should Investors Play the Stock?

Novo Nordisk NVO is expected to beat estimates when it reports its first-quarter 2025 results before the opening bell on May ...

Nasdaq7d

Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock?

Beyond diabetes and obesity, Novo Nordisk is diversifying its portfolio by developing Mim8 for hemophilia A, with plans to submit it for regulatory approval soon. Alhemo (concizumab) has been ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Novo Nordisk to sell Wegovy through telehealth firms

Trending now